Lymphoblastic Leukemia
Oncology
4
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
GS
Gilead SciencesFOSTER CITY, CA
2 programs2
DasatinibPhase 1Small Molecule1 trial
DasatinibPhase 1Small Molecule
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
2031
Kura OncologyDexamethasone
Gilead SciencesDasatinib
Clinical Trials (2)
Total enrollment: 98 patients across 2 trials
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Start: Nov 2023Est. completion: Dec 203390 patients
Phase 1/2Recruiting
Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
Start: Oct 2023Est. completion: Jun 20278 patients
Phase 1Active Not Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
3h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
3h ago
Office Administrator
SystImmune
3h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
3h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
3h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
3h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 98 patients
Small Molecule is the dominant modality (100% of programs)
3 companies competing in this space